drugset / Trial / NCT01496339
Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients
Phase 1/2
Unknown
50 enrolled
S-Evans Biosciences Co., Ltd.
Wenzhou Medical University · collabZhejiang University · collabZhenjiang First People's Hospital · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate whether the treatment of human menstrual blood-derived mesenchymal stem cells which would be applied to diabetes patients is safe and effective.
Timeline
- Start
- 2012-01
- Primary completion
- 2013-12
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Insulin | Protein / enzyme biologic | — | — |
| Subject | MenSCs | Cell therapy | 1e+06 cells/kg | Other |